Razi Cov Pars

Razi Cov Pars (Persian: رازی کوو پارس) is a COVID-19 vaccine developed by the Iranian Razi Vaccine and Serum Research Institute Razi Cov Pars is a covid-19 vaccine based on recombinant protein, which is being produced by Razi Vaccine and Serum Research Institute, Iran. This vaccine is the first injectable-intranasal recombinant protein corona vaccine.^[1][2][3]It's the second Iranian COVID-19 vaccine reaching human trials^[1] and is currently in phase III of clinical research during which it's compared to the Sinopharm BIBP vaccine.^[4][5]